showed significantly lower levels of activin A compared to responders. The combination of serum activin A and cervical length achieved a sensitivity of 100% and a specificity of 93.55% for the prediction of successful induction. Conclusion Late-term pregnancy is characterized by hyperexpression of placental activin A and increased maternal activin A secretion. By combining maternal serum activin A levels with cervical length, a good predictive model for the response to induction of labor was elaborated.
Introduction
Over the past two decades, the rate of induction of labor has increased up to 20% of pregnancies, and one of the challenges is still predicting which patients will have success [1] . Late-term pregnancy-a pregnancy that has reached between 41 0/7 weeks and 41 6/7 weeks of gestation-is the most common reason for induction of labor [2] . In fact, pregnancy beyond 42 weeks of gestationpost-term pregnancy-represents 5-8% of pregnancies and is characterized by significantly increased risks both for the fetus (higher incidence of perinatal mortality, low Apgar score, fetal macrosomia) and for the mother (labor dystocia, severe perineal injury related to macrosomia, and increased rate of cesarean delivery) [3, 4] . For this reasons, induction at 41-42 weeks represents the current best practice in many countries reducing the incidence of stillbirth without increasing fetal and maternal adverse outcomes [5] [6] [7] .
Despite the recent improvement of our knowledge on labor mechanisms, the pathogenesis of post-term pregnancy
Abstract
Purpose Feto-placental unit represents an important source of activin A, a member of transforming growth factors-β involved in the mechanisms of labor. No evidences are available on activin A in pregnancies beyond 41 weeks of gestation, where induction of labor is often required. The present study aimed to evaluate activin A maternal serum levels and placental mRNA expression in term and late-term pregnancy, with spontaneous or induced labor, and its possible role to predict the response to labor induction. Methods Maternal serum samples and placental specimens were collected from women with singleton pregnancy admitted for either term spontaneous labor (n = 23) or induction of labor for late-term pregnancy (n = 41), to evaluate activin A serum levels and placental mRNA expression. Univariate and multivariate analyses on activin A serum levels, maternal clinical parameters, and cervical length were conducted in women undergoing induction of labor. Results Maternal serum activin A levels and placental activin A mRNA expression in late-term pregnancies were significantly higher than at term. Late-term pregnancies who did not respond to induction of labor is still not clearly understood [8] . Parturition is an interplay between hormonal, mechanical, and inflammatory processes, where placenta, mother and fetus play a major role. However, the signals and mechanisms that synchronize the timing of human parturition remain largely unknown [9] . In addition, the response to induction of labor is highly variable, and several maternal and fetal factors (e.g., parity, gestational age, body mass index, maternal age, Bishop score, neonatal birth weight and gender, cervical length and biochemical markers) are involved [10] [11] [12] [13] . However, the risk of failure to labor induction is still hardly predictable; therefore, the availability of new reliable biomarkers to be used individually or in combination with known risk factors would be helpful in the clinical management of lateterm pregnancies [14] .
Among the molecules involved in the mechanisms of labor, activin A is a glycoprotein that belongs to the transforming growth factor-β superfamily and regulates several biological functions such as cell differentiation and apoptosis [15] [16] [17] . During pregnancy, feto-placental unit represents an important source of activin A: circulating maternal serum levels progressively increase throughout gestation from the first trimester until 28-week gestation and rising sharply thereafter until term [18] . The observation that at time of delivery activin A levels are the highest and that in labor activin A stimulates the release of prostaglandins (PGs) and production of interleukin 6 (IL-6) from amnion cell cultures in vitro supports a role of activin A in human parturition and inflammatory process [19] [20] [21] [22] .
On the basis of these evidences, the present study aimed to evaluate: (1) activin A maternal serum levels and placental mRNA expression in term and late-term pregnancy with spontaneous onset of labor or undergoing to labor induction and (2) the possible use of serum activin A as a biochemical marker for predicting the response to labor induction.
Materials and methods

Study population
This was a prospective study including healthy nulliparous women with singleton pregnancy admitted consecutively at the tertiary center Obstetric Unit of the Department of Molecular and Developmental Medicine (University Hospital of Siena, Siena, Italy) from July 2014 to March 2015 for either spontaneous onset of labor at term or induction of labor for late-term pregnancy. The local Ethics Committee approved the study (Prot. 325/05 B).
Term pregnancy was defined when gestational age was between 40 and 41 weeks of gestation, while late-term pregnancy when gestational age was between 41 0/7 and 41 6/7 weeks of gestation [2] . The spontaneous onset of labor was defined as the presence of regular and painful uterine contractions of sufficient frequency, intensity, and duration, resulting in progressive effacement and dilatation of the uterine cervix [23] . Women with multiple pregnancies, non-reassuring fetal testing, pregestational and gestational diabetes, placental abruption, pregnancyinduced hypertension and preeclampsia, intrauterine fetal growth restriction, fetal anomalies, vaginal bleeding, breech presentation, rupture of membranes, and clinical signs of infection were excluded from the study.
At admission, clinical characteristics such as maternal age, Bishop score, and cervical length were recorded, and a blood sample was collected from all the women included in the study. Cervical length was measured by ultrasound according to previously validated technical criteria [10] , using MyLab50 Esaote ultrasound scan equipment (MyLab Family group Esaote SpA, Genova, Italy) with a 4.5-7.0 MHz transvaginal probe. Maternal blood was obtained by venipuncture and centrifuged after 30 min from sampling at 4 °C (6000 g for 10 min). All serum samples were stored at −80 °C until assay.
Study population included a total of 64 women; among included patients, 23 delivered after spontaneous onset of labor either at term (n = 16) or late-term (n = 7), and 41 delivered after induction of labor for late-term pregnancy. Women admitted for induction of labor all presented an unfavorable cervix (Bishop score less than 6) and were induced with prostaglandins. Dinoprostone, in form of slow-release vaginal insert (Propess, Ferring, Copenhagen, DK), was administered in accordance with the international guidelines [24] . The vaginal insert is a preparation of prostaglandin E2 (PGE2) packaged in a hydrogel polymer matrix and designed for slow release of 10 mg dinoprostone at a rate of 0.3 mg/h over 12 h. It is applied in the posterior fornix when membranes are still intact [25] .
Fetal heart rate was monitored 30 min before and 1 h after dinoprostone administration in all induced patients. Oxytocin augmentation was started in the presence of unsatisfactory progress of labor or amniotomy. Both during induction and oxytocin stimulation, fetal heart rate and uterine contractions were monitored by cardiotocography. We considered as responders to induction those patients who went into active labor, defined as three or more regular uterine contractions lasting ≥40 s during 10 min with a cervical dilatation more than 4 cm. In group of induced labor, 31 (75.6%) women were responders, while in 10 (24.4%), the induction failed (no responders).
After delivery, placental specimens were collected from all groups of pregnant women, and each of them was immediately submerged in liquid nitrogen to allow subsequent RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR) and stored at −80 °C until assay.
Neonatal characteristics such as birth weight were recorded.
Activin A ELISA
Serum level of activin A was measured in duplicate using ELISA kit purchased from R&D (R&D, Abingdom, UK) according to the manufacturer's instructions. The intrassay and interassay coefficients of variations were 4.2 and 5%, respectively.
RNA extraction and cDNA preparation
Frozen placental tissue samples were disrupted and homogenized using Mixer Mill MM 300 (Quiagen, Milan, Italy). Total RNA was extracted with RNeasy Protect Mini Kit and then treated with RNase-free DNase according to manufacturer instructions (RNase protect Mini Kit Qiagen, Hilden, Germany). RNA was quantified by UV absorption (OD260) using Nanodrop (Celbio, Milan, Italy), and RNA purity was determined from the OD260:OD280. The purified RNA was stored at −80 °C until cDNA preparation. About 200 ng of RNA were reverse transcribed to prepare complementary DNA (cDNA). Reversion was carried out in a reaction volume of 20 µl containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 5 mM random hexamer primer, 2.7 mM deoxynucleoside triphosphate, and 10 U/Ml SuperScript II reverse transcriptase (all reagents obtained from Invitrogen Life Technologies, Milan, Italy). Negative control for each reaction consisted of retrotranscription performed in the absence of reverse transcriptase enzyme (RT) or in the absence of RNA samples (H 2 O RT). RNA was initially denatured at 85 °C for 5 min. The reaction mixture was then added, and RT was performed at 50 °C for 40 min. The reaction was stopped by denaturing the enzyme at 85 °C for 15 min. 1 µl of cDNA was subsequently subjected to qRT-PCR.
Real-time polymerase chain reaction
Differences in mRNA expression of activin A were compared by qRT-PCR (TaqMan PCR, Applied Biosystems, Weiterstadt, Germany), using an Opticon 2 thermal cycler (MJ Research, Bio-Rad Laboratories, Waltham, MA). The housekeeping gene 18S (assay identification no.Hs 99999901_s1) was used as an internal standard. All samples were run in triplicate on 96-well optical PCR plates (Applied Biosystems), optimized to the universal PCR protocol of the manufacturer, with a TaqMan Universal PCR Master Mix (Applied Biosystems). TaqMan probe for Activin A (assay identification n°. Hs99999043_m1) was taken from the commercially available Assays on Demand (Applied Biosystems). After initial denaturation for 10 min at 95 °C, denaturation at the subsequent 40 cycles was performed for 15 s at 95 °C, followed by primer annealing and elongation at 60 °C for 1 min. The CT method was applied as a comparative method of quantification.
Statistical analysis
All data were analyzed with either Prism (GraphPad Software Inc., San Diego, California,USA) or MedCalc (MedCalc Software bvba, Mariakerke, Belgium) software.
Normal distribution of quantitative clinical data was previously verified using the Kolmogorov-Smirnov test. Descriptive statistics included means and standard deviations. In the univariate analysis, differences of quantitative clinical data between groups of responders and not responders were assessed by unpaired t test. Qualitative variables were compared by the Yates-corrected χ 2 test. Backward stepwise logistic regression was utilized to validate the influence of the principal variables (cervical length, Bishop score, and activin A serum levels) in the response of labor induction.
The cut-off points for defining cervical length and activin A levels for prediction of the response to labor induction in late-term pregnancy were chosen by receiving operator characteristics curve (ROC) analysis as the minimum distance from the ideal point of both sensitivity (SE) and specificity (SP) equal to 100%. Using the best cut-off values indicated by the ROC analysis, the specificity, sensitivity, positive, and negative predictive values with their respective of 95% confidence bounds, likelihood ratios, and area under the curve were calculated. The statistical significance was achieved when p < 0.05.
Results
Maternal serum activin A
Maternal serum activin A levels resulted significantly higher in women with late-term pregnancy than in those at term (6.39 ± 1.95 vs 5.03 ± 1.62 ng/ml, p < 0.05) (Fig. 1a) . No difference was observed in late-term patients between those who delivered spontaneously and those who delivered after induction (Fig. 1b) . Comparing late-term pregnancies responding and no responding to induction of labor, no responders showed significantly lower levels of maternal serum activin A than responders (4.79 ± 1.53 vs 6.73 ± 2.03 ng/ml, p < 0.01) (Fig. 1c) .
Placenta activin A mRNA expression
Similarly to maternal serum levels, placental activin A mRNA expression levels were significantly higher in women with late-term pregnancy than in those at term (0.60 ± 0.37 vs 0.17 ± 0.06 p < 0.01) (Fig. 2a) ; no difference was found between women who delivered spontaneously late-term and women who delivered after labor induction (Fig. 2b) . In the induction group, no responders showed significantly lower mRNA expression (0.43 ± 0.10 vs 0.93 ± 0.42 p < 0.01) than the group of responders to induction (Fig. 2c ).
Combined predictive model for success to induction of labor in late-term pregnancies
Maternal clinical characteristics, Bishop score, and cervical length showed a statistically significant difference between responding and no responding patients to induction of labor (p < 0.01 and p < 0.001 respectively); on the contrary, maternal age and fetal birthweight did not show any statistically significant difference between the groups ( Table 1) .
The multivariate analysis retained in the model cervical length and maternal serum activin A. By using the ROC curve analysis, maternal serum activin A at a cut-off value of >4643 ng/ml achieved a sensitivity of 80% (95% CI 44.4-97.5) and a specificity of 80.65% (95% CI 62.5-92.5) as a single marker for the prediction of success to induction of labor (AUC 0.858; 95% CI 0.714-0.947, p < 0.0001), with a positive and negative likelihood ratio of 4.03 and 0.24, respectively. Cervical length at cut-off value of ≤24 mm achieved a sensitivity of 100.0% (95% CI 69.2-100) and a specificity of 81.10% (95% CI 70.2-96.4) as a single maker for the prediction of success to induction of labor (AUC 0.921; 95% CI 0.793 to 0.982, p < 0.0001). The estimated probability of the resulting logistic model combining serum activin A and cervical length achieved a sensitivity of 100% (95% CI 69.2-100.0) and a specificity of 93.55% (95% CI 78.6-99.2) (AUC 0.984; 95% CI 0.885-1.000, p < 0.0001) using as decision probability cut-off value >0.7221 (Fig. 3) . 
Discussion
The present study showed that maternal serum and placental levels of activin A are higher in late-term pregnancy. Moreover, considering women undergoing induction of labor for late-term pregnancy, response to labor induction is associated with higher maternal serum and placental levels of activin A. In addition, cervical length combined to maternal serum activin A provide a significant contribution in the prediction of success to labor induction in late-term pregnancy. Activin A is suggested to play a role in the initiation and/or control of human parturition. In fact, maternal activin A levels at delivery are higher in laboring women than those not in labor at the same gestational age; moreover, activin A stimulates PG release from cultured amnion cells [19] [20] [21] . Our present findings, showing high activin A levels in maternal circulation and placental tissue in women with late-term pregnancy respect to women at term, support that feto-placental unit increases activin A secretion with advancing gestational age [17, 18] . In addition, activin A may play a role in feto-placental blood perfusion, counteracting the reduced fetal oxygenation in late-term pregnancies [26, 27] , and in increasing apoptosis [28] , a physiological phenomenon affecting the trophoblast in prolonged pregnancies [29] .
Activins are proteins which modulate cytokine cascade, driving the inflammatory response [30, 31] . In particular, activin A represents a modulator of immune function in utero-placental tissues, corroborating the importance of this factor in human parturition where it may be involved in the regulation of the inflammatory pathways occurring during labor [32, 33] . In fact, it is well-known that activin A increases amnion-derived IL-6 production and decreases TNF-alpha production by chorio-decidual and placental explants. In addition, circulating levels of activin A increase before the secretion of other acute phase pro-inflammatory cytokines [30] . Activin A has also been shown to contribute to dendritic cell incomplete activation during late pregnancy, suggesting an involvement in the regulating mechanisms operated by the maternal immune system to maintain fetal tolerance during late pregnancy [34] .
Concerning the influence of clinical parameters on the response to labor induction, cervical length and activin A resulted independent predictive variables of response in late-term pregnancy. The relationship between clinical evaluation of the cervix and spontaneous onset of labor has been known for many years [35] . Recent evidences attest that sonographic parameters are better predictors of induction response compared to Bishop score that gives an approximate and non-reproducible evaluation of preinduction cervical ripening by digital examination [36] [37] [38] [39] . Although Bishop score represents a good tool to identify women who are more likely to respond to the induction of labor, our findings confirm that ultrasound measurement of cervical length is better in terms of reliability and reproducibility and it represents an independent predictor of the response to induction of labor [39] .
Concerning the clinical usefulness of activin A as a putative biomarker for the prediction of success to labor induction in late-term pregnancy, our findings showed that activin A serum levels provided a good performance.
Higher the activin A levels, the higher the probability of responding to induction of labor in late-term pregnancy. To our knowledge, this is the first study evaluating serum and placental activin A levels in late-term pregnancies compared to term ones, suggesting the contribution of this glycoprotein in labor mechanisms. However, our results are limited by the small number of study population and need to be confirmed in further studies with larger samples. Nevertheless, the predictive model, combining serum activin A and cervical length, showed a good value of accuracy, resulting a potential tool helping the clinician to predict the success of induction.
In conclusion, in late-term pregnancies with unfavorable Bishop score undergoing to induction of labor, an evaluation of maternal serum activin A levels, in combination with cervical length, may be useful to predict the response to induction.
